Literature DB >> 26094116

Low-volume contrast medium protocol for comprehensive cardiac and aortoiliac CT assessment in the context of transcatheter aortic valve replacement.

Lucas L Geyer1, Carlo Nicola De Cecco2, U Joseph Schoepf3, Justin R Silverman2, Aleksander W Krazinski2, Fabian Bamberg4, Daniel H Steinberg5.   

Abstract

RATIONALE AND
OBJECTIVES: To investigate the diagnostic performance of a comprehensive computed tomography (CT) protocol for both cardiac and aortoiliac evaluation of patients considered for transcatheter aortic valve replacement (TAVR) using a single, low-volume contrast medium (CM) injection.
MATERIALS AND METHODS: Forty-four TAVR candidates were retrospectively analyzed. All underwent retrospectively electrocardiogram-gated cardiac CT followed by high-pitch CT angiography of the aortoiliac vasculature using one of two single injection protocols of 320 mgI/mL iodine CM: group A (n = 22), iodine delivery rate-based (1.28 gI/s), 60-mL CM volume, 4.0 mL/s flow rate; group B (n = 22), clinical routine protocol, 100-mL CM volume, 4.0 mL/s flow rate. Mean arterial attenuation, signal-to-noise ratio (SNR), and contrast-to-noise ratio (CNR) were calculated. Subjective image quality was assessed.
RESULTS: Aortic root and iliofemoral dimensions could be analyzed in all cases. Patient characteristics showed no significant differences. Mean attenuation at the levels of the aortic root (285.8 ± 83.0 HU vs 327.5 ± 70.8 HU, P = .080) and the iliofemoral access route (256.8 ± 88.5 HU vs 307.5 ± 93.2 HU, P = .071), as well as SNR and CNR were nonsignificantly lower in group A compared to group B. Subjective image quality was equivalent.
CONCLUSIONS: In multimorbid TAVR patients, the performance of a combined CT protocol using a single low-volume CM bolus is feasible with maintained image quality compared to a standard protocol.
Copyright © 2015 AUR. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aortic stenosis; aortoiliac CT angiography; contrast medium; dual-source CT; transcatheter aortic valve replacement

Mesh:

Substances:

Year:  2015        PMID: 26094116     DOI: 10.1016/j.acra.2015.03.018

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  6 in total

Review 1.  Noninvasive aortic imaging.

Authors:  Vinit Baliyan; Daniel Verdini; Nandini M Meyersohn
Journal:  Cardiovasc Diagn Ther       Date:  2018-04

Review 2.  Role of Imaging in Transcatheter Aortic Valve Replacement.

Authors:  Corinna Storz; Tobias Geisler; Mike Notohamiprodjo; Konstantin Nikolaou; Fabian Bamberg
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-10

3.  Computer-aided evaluation of low-dose and low-contrast agent third-generation dual-source CT angiography prior to transcatheter aortic valve implantation (TAVI).

Authors:  Peter Dankerl; Matthias Hammon; Hannes Seuss; Monique Tröbs; Annika Schuhbaeck; Michaela M Hell; Alexander Cavallaro; Stephan Achenbach; Michael Uder; Mohamed Marwan
Journal:  Int J Comput Assist Radiol Surg       Date:  2016-09-07       Impact factor: 2.924

4.  High-pitch dual-source CT angiography without ECG-gating for imaging the whole aorta: intraindividual comparison with standard pitch single-source technique without ECG gating.

Authors:  Carmelinda Manna; Mario Silva; Rocco Cobelli; Sara Poggesi; Cristina Rossi; Nicola Sverzellati
Journal:  Diagn Interv Radiol       Date:  2017 Jul-Aug       Impact factor: 2.630

5.  Very low intravenous contrast volume protocol for computed tomography angiography providing comprehensive cardiac and vascular assessment prior to transcatheter aortic valve replacement in patients with chronic kidney disease.

Authors:  Todd C Pulerwitz; Omar K Khalique; Tamim N Nazif; Anna Rozenshtein; Gregory D N Pearson; Rebecca T Hahn; Torsten P Vahl; Susheel K Kodali; Isaac George; Martin B Leon; Belinda D'Souza; Ming Jack Po; Andrew J Einstein
Journal:  J Cardiovasc Comput Tomogr       Date:  2016-03-28

Review 6.  Vascular Imaging Before Transcatheter Aortic Valve Replacement (TAVR): Why and How?

Authors:  Damiano Caruso; Russell D Rosenberg; Carlo N De Cecco; Stefanie Mangold; Julian L Wichmann; Akos Varga-Szemes; Daniel H Steinberg; Andrea Laghi; U Joseph Schoepf
Journal:  Curr Cardiol Rep       Date:  2016-02       Impact factor: 2.931

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.